Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118757793 | 11875779 | 3 | F | 19990105 | 20160926 | 20151229 | 20160929 | EXP | JP-GLAXOSMITHKLINE-A200601566 | GLAXOSMITHKLINE | 26.70 | YR | M | Y | 0.00000 | 20160929 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118757793 | 11875779 | 1 | PS | Abacavir sulfate + lamivudine | ABACAVIR SULFATELAMIVUDINE | 1 | Oral | 1 DF, UNK | Y | 21652 | 1 | DF | TABLET | ||||||
| 118757793 | 11875779 | 2 | SS | LAMIVUDINE AND ZIDOVUDINE | LAMIVUDINEIDOVUDINE | 1 | Oral | 2 DF, UNK | Y | 0 | 2 | DF | TABLET | ||||||
| 118757793 | 11875779 | 3 | SS | Abacavir sulphate | ABACAVIR | 1 | Oral | 300 MG, BID | Y | 0 | 300 | MG | TABLET | BID | |||||
| 118757793 | 11875779 | 4 | SS | TIVICAY | DOLUTEGRAVIR SODIUM | 1 | Oral | 50 MG, UNK | 0 | 50 | MG | FILM-COATED TABLET | |||||||
| 118757793 | 11875779 | 5 | SS | NORVIR | RITONAVIR | 1 | 100 MG, BID | 220600 | MG | Y | 0 | 100 | MG | TABLET | BID | ||||
| 118757793 | 11875779 | 6 | SS | NORVIR | RITONAVIR | 1 | 200 MG, BID | 220600 | MG | Y | 0 | 200 | MG | TABLET | BID | ||||
| 118757793 | 11875779 | 7 | SS | NORVIR | RITONAVIR | 1 | 300 MG, BID | 220600 | MG | Y | 0 | 300 | MG | TABLET | BID | ||||
| 118757793 | 11875779 | 8 | SS | NORVIR | RITONAVIR | 1 | 400 MG, BID | 220600 | MG | Y | 0 | 400 | MG | TABLET | BID | ||||
| 118757793 | 11875779 | 9 | SS | NORVIR | RITONAVIR | 1 | 400 MG, BID | 220600 | MG | Y | 0 | 400 | MG | TABLET | BID | ||||
| 118757793 | 11875779 | 10 | SS | NORVIR | RITONAVIR | 1 | 100 MG, UNK | 220600 | MG | Y | 0 | 100 | MG | TABLET | |||||
| 118757793 | 11875779 | 11 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 6 DF, UNK | Y | 0 | 6 | DF | CAPSULE | ||||||
| 118757793 | 11875779 | 12 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 4 DF, UNK | Y | 0 | 4 | DF | CAPSULE | ||||||
| 118757793 | 11875779 | 13 | SS | ZERIT | STAVUDINE | 1 | 30 MG, BID | 8760 | MG | Y | 0 | 30 | MG | TABLET | BID | ||||
| 118757793 | 11875779 | 14 | SS | ZERIT | STAVUDINE | 1 | 30 MG, BID | 8760 | MG | Y | 0 | 30 | MG | TABLET | BID | ||||
| 118757793 | 11875779 | 15 | C | MILTAX | VIDARABINE | 1 | Transdermal | ARBITRARILY | 0 | ||||||||||
| 118757793 | 11875779 | 16 | C | CROSS EIGHT M | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | 1-2 TIMES/WEEK | U | 0 | 1 | KIU | INJECTION | ||||||
| 118757793 | 11875779 | 17 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | TABLET | ||||||
| 118757793 | 11875779 | 18 | C | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 800 MG, UNK | U | 0 | 800 | MG | TABLET | ||||||
| 118757793 | 11875779 | 19 | C | NORVIR | RITONAVIR | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 118757793 | 11875779 | 20 | C | PREZISTA | DARUNAVIR ETHANOLATE | 1 | 900 MG, UNK | 0 | 900 | MG | |||||||||
| 118757793 | 11875779 | 21 | C | PREZISTANAIVE | DARUNAVIR | 1 | 800 MG, QD | 0 | 800 | MG | QD | ||||||||
| 118757793 | 11875779 | 22 | C | URSO | URSODIOL | 1 | 200 MG, TID | 0 | 200 | MG | TID | ||||||||
| 118757793 | 11875779 | 23 | C | REFLEX TABLETS | 2 | 15 MG, QD | 0 | 15 | MG | QD | |||||||||
| 118757793 | 11875779 | 24 | C | REFLEX TABLETS | 2 | 0 | |||||||||||||
| 118757793 | 11875779 | 25 | C | LOXONIN | LOXOPROFEN SODIUM | 1 | 60 MG, QD | 0 | 60 | MG | QD | ||||||||
| 118757793 | 11875779 | 26 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 118757793 | 11875779 | 27 | C | UNKNOWN DRUG | UNSPECIFIED INGREDIENT | 1 | 1000 IU, UNK | 0 | 1000 | IU | |||||||||
| 118757793 | 11875779 | 28 | C | UNKNOWN DRUG | UNSPECIFIED INGREDIENT | 1 | 2000-6000IU | 0 | |||||||||||
| 118757793 | 11875779 | 29 | C | UNKNOWN DRUG | UNSPECIFIED INGREDIENT | 1 | 1000 IU, UNK | 0 | 1000 | IU | |||||||||
| 118757793 | 11875779 | 30 | C | HARVONI | LEDIPASVIRSOFOSBUVIR | 1 | 1 DF, QD | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118757793 | 11875779 | 1 | HIV infection |
| 118757793 | 11875779 | 2 | HIV infection |
| 118757793 | 11875779 | 3 | HIV infection |
| 118757793 | 11875779 | 4 | HIV infection |
| 118757793 | 11875779 | 5 | HIV infection |
| 118757793 | 11875779 | 11 | HIV infection |
| 118757793 | 11875779 | 13 | HIV infection |
| 118757793 | 11875779 | 15 | Factor VIII deficiency |
| 118757793 | 11875779 | 16 | Factor VIII deficiency |
| 118757793 | 11875779 | 17 | Acquired immunodeficiency syndrome |
| 118757793 | 11875779 | 18 | Acquired immunodeficiency syndrome |
| 118757793 | 11875779 | 19 | HIV infection |
| 118757793 | 11875779 | 20 | HIV infection |
| 118757793 | 11875779 | 21 | HIV infection |
| 118757793 | 11875779 | 22 | Hepatic function abnormal |
| 118757793 | 11875779 | 23 | Depression |
| 118757793 | 11875779 | 24 | Adjustment disorder |
| 118757793 | 11875779 | 25 | Headache |
| 118757793 | 11875779 | 26 | Sensory disturbance |
| 118757793 | 11875779 | 27 | Haemophilia |
| 118757793 | 11875779 | 28 | Haemorrhage prophylaxis |
| 118757793 | 11875779 | 29 | Factor VIII deficiency |
| 118757793 | 11875779 | 30 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118757793 | 11875779 | OT |
| 118757793 | 11875779 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118757793 | 11875779 | Haemorrhagic diathesis | |
| 118757793 | 11875779 | Lipodystrophy acquired | |
| 118757793 | 11875779 | Liver function test abnormal | |
| 118757793 | 11875779 | Vascular insufficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118757793 | 11875779 | 1 | 20050428 | 20090126 | 0 | |
| 118757793 | 11875779 | 2 | 20010524 | 20050427 | 0 | |
| 118757793 | 11875779 | 3 | 20010524 | 20050427 | 0 | |
| 118757793 | 11875779 | 4 | 20140909 | 0 | ||
| 118757793 | 11875779 | 5 | 19980330 | 19980401 | 0 | |
| 118757793 | 11875779 | 6 | 19980402 | 19980403 | 0 | |
| 118757793 | 11875779 | 7 | 19980404 | 19980405 | 0 | |
| 118757793 | 11875779 | 8 | 19980406 | 19990820 | 0 | |
| 118757793 | 11875779 | 9 | 19990830 | 19990914 | 0 | |
| 118757793 | 11875779 | 10 | 20110712 | 20140908 | 0 | |
| 118757793 | 11875779 | 11 | 20010524 | 20061127 | 0 | |
| 118757793 | 11875779 | 12 | 20061128 | 20090126 | 0 | |
| 118757793 | 11875779 | 13 | 19980327 | 19980820 | 0 | |
| 118757793 | 11875779 | 14 | 19990830 | 20000131 | 0 | |
| 118757793 | 11875779 | 15 | 20050815 | 0 | ||
| 118757793 | 11875779 | 16 | 20050815 | 0 | ||
| 118757793 | 11875779 | 17 | 20090127 | 0 | ||
| 118757793 | 11875779 | 18 | 20090127 | 20090518 | 0 | |
| 118757793 | 11875779 | 19 | 20090519 | 20110711 | 0 | |
| 118757793 | 11875779 | 20 | 20090519 | 20110425 | 0 | |
| 118757793 | 11875779 | 21 | 20110426 | 20140908 | 0 | |
| 118757793 | 11875779 | 22 | 20150401 | 20151209 | 0 | |
| 118757793 | 11875779 | 23 | 20150401 | 0 | ||
| 118757793 | 11875779 | 25 | 20150401 | 20150406 | 0 | |
| 118757793 | 11875779 | 26 | 20160315 | 0 | ||
| 118757793 | 11875779 | 27 | 20150401 | 20150608 | 0 | |
| 118757793 | 11875779 | 28 | 20150609 | 20150803 | 0 | |
| 118757793 | 11875779 | 29 | 20150804 | 0 | ||
| 118757793 | 11875779 | 30 | 20151110 | 20160201 | 0 |